Initiates Coverage on Dynatronics (NASDAQ:DYNT) began coverage on shares of Dynatronics (NASDAQ:DYNTGet Rating) in a research report report published on Monday. The firm issued a hold rating on the medical equipment provider’s stock.

Other equities analysts have also issued research reports about the company. TheStreet lowered Dynatronics from a c- rating to a d+ rating in a research note on Friday, February 11th. Roth Capital restated a buy rating on shares of Dynatronics in a research note on Thursday, February 17th. Finally, Zacks Investment Research lowered Dynatronics from a hold rating to a sell rating in a research note on Wednesday, April 6th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from, the stock has an average rating of Buy and a consensus target price of $2.13.

Shares of NASDAQ DYNT opened at $0.73 on Monday. The firm has a market cap of $13.14 million, a P/E ratio of 8.13 and a beta of -0.06. The company has a current ratio of 2.38, a quick ratio of 1.30 and a debt-to-equity ratio of 0.12. Dynatronics has a 1-year low of $0.67 and a 1-year high of $1.79. The business’s 50 day moving average is $0.76 and its 200-day moving average is $1.04.

Dynatronics (NASDAQ:DYNTGet Rating) last announced its earnings results on Thursday, February 10th. The medical equipment provider reported ($0.09) earnings per share for the quarter. Dynatronics had a return on equity of 12.52% and a net margin of 4.50%. The firm had revenue of $10.53 million for the quarter. During the same quarter in the prior year, the business posted ($0.06) EPS. Analysts forecast that Dynatronics will post -0.21 EPS for the current year.

Several institutional investors and hedge funds have recently modified their holdings of the company. Citadel Advisors LLC bought a new position in shares of Dynatronics in the 3rd quarter valued at $30,000. Goldman Sachs Group Inc. bought a new position in shares of Dynatronics in the 3rd quarter valued at $56,000. Renaissance Technologies LLC increased its stake in shares of Dynatronics by 11.3% in the 3rd quarter. Renaissance Technologies LLC now owns 801,165 shares of the medical equipment provider’s stock valued at $1,170,000 after purchasing an additional 81,600 shares during the last quarter. Finally, Millennium Management LLC bought a new position in shares of Dynatronics in the 3rd quarter valued at $120,000. Institutional investors own 9.95% of the company’s stock.

About Dynatronics (Get Rating)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.

Further Reading

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with's FREE daily email newsletter.